O	0	10	Randomized
O	11	21	controlled
O	22	27	trial
O	28	30	of
B-intervention	31	39	exercise
I-intervention	40	48	training
O	49	51	in
O	52	66	postmenopausal
O	67	73	breast
O	74	80	cancer
O	81	90	survivors
O	90	91	:
O	92	107	cardiopulmonary
O	108	111	and
O	112	119	quality
O	120	122	of
O	123	127	life
O	128	136	outcomes
O	136	137	.

O	138	140	To
O	141	150	determine
O	151	154	the
O	155	162	effects
O	163	165	of
O	166	174	exercise
O	175	183	training
O	184	186	on
O	187	202	cardiopulmonary
O	203	211	function
O	212	215	and
O	216	223	quality
O	224	226	of
O	227	231	life
O	232	233	(
O	233	236	QOL
O	236	237	)
O	238	240	in
O	241	255	postmenopausal
O	256	262	breast
O	263	269	cancer
O	270	279	survivors
O	280	283	who
O	284	287	had
O	288	297	completed
O	298	305	surgery
O	305	306	,
O	307	319	radiotherapy
O	319	320	,
O	321	324	and
O	324	325	/
O	325	327	or
O	328	340	chemotherapy
O	341	345	with
O	346	348	or
O	349	356	without
O	357	364	current
O	365	372	hormone
O	373	380	therapy
O	381	384	use
O	384	385	.

B-total-participants	386	391	Fifty
I-total-participants	391	392	-
I-total-participants	392	397	three
B-eligibility	398	412	postmenopausal
I-eligibility	413	419	breast
I-eligibility	420	426	cancer
I-eligibility	427	436	survivors
O	437	441	were
O	442	450	randomly
O	451	459	assigned
O	460	462	to
O	463	465	an
O	466	474	exercise
O	475	476	(
O	476	477	n
O	478	479	=
B-intervention-participants	480	482	25
O	482	483	)
O	484	486	or
B-control	487	494	control
O	495	496	(
O	496	497	n
O	498	499	=
B-control-participants	500	502	28
O	502	503	)
O	504	509	group
O	509	510	.

O	511	514	The
O	515	523	exercise
O	524	529	group
O	530	537	trained
O	538	540	on
O	541	546	cycle
O	547	557	ergometers
O	558	563	three
O	564	569	times
O	570	573	per
O	574	578	week
O	579	582	for
O	583	585	15
O	586	591	weeks
O	592	594	at
O	595	596	a
O	597	602	power
O	603	609	output
O	610	614	that
O	615	623	elicited
O	624	627	the
O	628	639	ventilatory
O	640	650	equivalent
O	651	654	for
O	655	661	carbon
O	662	669	dioxide
O	669	670	.

O	671	674	The
O	675	682	control
O	683	688	group
O	689	692	did
O	693	696	not
O	697	702	train
O	702	703	.

O	704	707	The
O	708	715	primary
O	716	724	outcomes
O	725	729	were
B-outcome-Measure	730	737	changes
I-outcome-Measure	738	740	in
I-outcome-Measure	741	745	peak
I-outcome-Measure	746	752	oxygen
I-outcome-Measure	753	764	consumption
O	765	768	and
B-outcome-Measure	769	776	overall
I-outcome-Measure	777	780	QOL
I-outcome-Measure	781	785	from
I-outcome-Measure	786	794	baseline
I-outcome-Measure	795	797	to
I-outcome-Measure	798	814	postintervention
O	814	815	.

O	816	820	Peak
O	821	827	oxygen
O	828	839	consumption
O	840	843	was
O	844	852	assessed
O	853	855	by
O	856	857	a
O	858	864	graded
O	865	873	exercise
O	874	878	test
O	879	884	using
O	885	888	gas
O	889	897	exchange
O	898	906	analysis
O	906	907	.

O	908	915	Overall
O	916	919	QOL
O	920	923	was
O	924	932	assessed
O	933	935	by
O	936	939	the
O	940	950	Functional
O	951	961	Assessment
O	962	964	of
O	965	971	Cancer
O	972	979	Therapy
O	979	980	-
O	980	986	Breast
O	987	992	scale
O	992	993	.

B-total-participants	994	999	Fifty
I-total-participants	999	1000	-
I-total-participants	1000	1003	two
O	1004	1016	participants
O	1017	1026	completed
O	1027	1030	the
O	1031	1036	trial
O	1036	1037	.

O	1038	1041	The
O	1042	1050	exercise
O	1051	1056	group
O	1057	1066	completed
O	1067	1069	98
O	1069	1070	.
O	1070	1071	4
O	1071	1072	%
O	1073	1075	of
O	1076	1079	the
O	1080	1088	exercise
O	1089	1097	sessions
O	1097	1098	.

O	1099	1107	Baseline
O	1108	1114	values
O	1115	1118	for
B-outcome	1119	1123	peak
I-outcome	1124	1130	oxygen
I-outcome	1131	1142	consumption
O	1143	1144	(
O	1144	1145	P
O	1146	1147	=
O	1147	1148	.
O	1148	1151	254
O	1151	1152	)
O	1153	1156	and
B-outcome	1157	1164	overall
I-outcome	1165	1168	QOL
O	1169	1170	(
O	1170	1171	P
O	1172	1173	=
O	1173	1174	.
O	1174	1177	286
O	1177	1178	)
O	1179	1182	did
O	1183	1186	not
O	1187	1193	differ
O	1194	1201	between
O	1202	1208	groups
O	1208	1209	.

B-outcome	1210	1214	Peak
I-outcome	1215	1221	oxygen
I-outcome	1222	1233	consumption
O	1234	1243	increased
O	1244	1246	by
O	1247	1248	0
O	1248	1249	.
O	1249	1251	24
O	1252	1253	L
O	1253	1254	/
O	1254	1257	min
O	1258	1260	in
O	1261	1264	the
O	1265	1273	exercise
O	1274	1279	group
O	1279	1280	,
O	1281	1288	whereas
O	1289	1291	it
O	1292	1301	decreased
O	1302	1304	by
O	1305	1306	0
O	1306	1307	.
O	1307	1309	05
O	1310	1311	L
O	1311	1312	/
O	1312	1315	min
O	1316	1318	in
O	1319	1322	the
O	1323	1330	control
O	1331	1336	group
O	1337	1338	(
O	1338	1342	mean
O	1343	1353	difference
O	1353	1354	,
O	1355	1356	0
O	1356	1357	.
O	1357	1359	29
O	1360	1361	L
O	1361	1362	/
O	1362	1365	min
O	1365	1366	;
O	1367	1369	95
O	1369	1370	%
O	1371	1381	confidence
O	1382	1390	interval
O	1391	1392	[
O	1392	1394	CI
O	1394	1395	]
O	1395	1396	,
O	1397	1398	0
O	1398	1399	.
O	1399	1401	18
O	1402	1404	to
O	1405	1406	0
O	1406	1407	.
O	1407	1409	40
O	1409	1410	;
O	1411	1412	P
O	1413	1414	<
O	1414	1415	.
O	1415	1418	001
O	1418	1419	)
O	1419	1420	.

B-outcome	1421	1428	Overall
I-outcome	1429	1432	QOL
O	1433	1442	increased
O	1443	1445	by
B-iv-cont-mean	1446	1447	9
I-iv-cont-mean	1447	1448	.
I-iv-cont-mean	1448	1449	1
I-iv-cont-mean	1450	1456	points
O	1457	1459	in
O	1460	1463	the
O	1464	1472	exercise
O	1473	1478	group
O	1479	1487	compared
O	1488	1492	with
B-cv-cont-mean	1493	1494	0
I-cv-cont-mean	1494	1495	.
I-cv-cont-mean	1495	1496	3
I-cv-cont-mean	1497	1503	points
O	1504	1506	in
O	1507	1510	the
O	1511	1518	control
O	1519	1524	group
O	1525	1526	(
O	1526	1530	mean
O	1531	1541	difference
O	1541	1542	,
O	1543	1544	8
O	1544	1545	.
O	1545	1546	8
O	1547	1553	points
O	1553	1554	;
O	1555	1557	95
O	1557	1558	%
O	1559	1561	CI
O	1561	1562	,
O	1563	1564	3
O	1564	1565	.
O	1565	1566	6
O	1567	1569	to
O	1570	1572	14
O	1572	1573	.
O	1573	1574	0
O	1574	1575	;
O	1576	1577	P
O	1578	1579	=
O	1579	1580	.
O	1580	1583	001
O	1583	1584	)
O	1584	1585	.

O	1586	1593	Pearson
O	1594	1606	correlations
O	1607	1616	indicated
O	1617	1621	that
O	1622	1628	change
O	1629	1631	in
B-outcome	1632	1636	peak
I-outcome	1637	1643	oxygen
I-outcome	1644	1655	consumption
O	1656	1666	correlated
O	1667	1671	with
O	1672	1678	change
O	1679	1681	in
B-outcome	1682	1689	overall
I-outcome	1690	1693	QOL
O	1694	1695	(
O	1695	1696	r
O	1697	1698	=
O	1699	1700	0
O	1700	1701	.
O	1701	1703	45
O	1703	1704	;
O	1705	1706	P
O	1707	1708	<
O	1708	1709	.
O	1709	1711	01
O	1711	1712	)
O	1712	1713	.

O	1714	1722	Exercise
O	1723	1731	training
O	1732	1735	had
O	1736	1746	beneficial
O	1747	1754	effects
O	1755	1757	on
O	1758	1773	cardiopulmonary
O	1774	1782	function
O	1783	1786	and
O	1787	1790	QOL
O	1791	1793	in
O	1794	1808	postmenopausal
O	1809	1815	breast
O	1816	1822	cancer
O	1823	1832	survivors
O	1832	1833	.
